Norbornene modified peptides and their labelling with tetrazine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9968690
SERIAL NO

14373292

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to a polypeptide comprising an amino acid having a norbornene group. Suitably said norbornene group is present as an amino acid residue of a norbornene lysine. The invention also relates to a method of producing a polypeptide comprising a norbornene group, said method comprising genetically incorporating an amino acid comprising a norbornene group into a polypeptide.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
UNITED KINGDOM RESEARCH AND INNOVATIONWILTSHIRE WILTSHIRE

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chin, Jason Cambridgeshire, GB 30 410
Deiters, Alexander Raleigh, US 29 423
Lang, Kathrin Cambridge, GB 4 4

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 15, 2025
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 15, 2029
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00